IQ4I Published “Non-alcoholic steatohepatitis (NASH): Disease and pipeline analysis”

Nonalcoholic steatohepatitis (NASH) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of NASH. The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins and RNA-based therapeutics, but excludes Off-label, symptom… Continue reading IQ4I Published “Non-alcoholic steatohepatitis (NASH): Disease and pipeline analysis”